KRRO
Korro Bio, Inc.
There isn't enough reported data to score KRRO yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
KRRO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Weak | |
| Unavailable |
KRRO's profitability and cash flow are currently weak. There isn't enough data to rate its revenue and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
KRRO PE Valuation
KRRO has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
KRRO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| Low |
Analysts expect KRRO's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
KRRO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$9.07 | +$0.32 |
| Q2 2026 | -$10.01 | -$0.28 |
| Q1 2026 | -$11.68 | -$2.26 |
| Q4 2025 | -$12.48 | -$3.11 |
| Q3 2025 | -$9.39 | +$49.67 |
| Q2 2025 | -$9.73 | +$62.57 |
| Q1 2025 | -$9.42 | +$75.23 |
| Q4 2024 | -$9.37 | +$100.17 |
KRRO is still losing money, but far less than before: $9.07 per share over the past year, against $131.50 at its worst in mid-2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over KRRO on earnings quality, reporting a profit while its opponent remains loss making.
KRRO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2021 | $9.4M | +10% |
| Q1 2021 | $4.7M | -36% |
| Q4 2020 | $10M | +111% |
KRRO's revenue has slid since its 2020 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -3901% | N/A |
| Q3 2025 | -1765% | N/A |
| Q2 2025 | -1863% | N/A |
| Q1 2025 | -981% | N/A |
| Q2 2021 | -186% | -113 points |
| Q1 2021 | -434% | -356 points |
| Q4 2020 | -103% | +35 points |
| Q3 2020 | -48% | N/A |
KRRO's operating margin was −3901% last quarter, down 3715 points from the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over KRRO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
KRRO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$13M | +$4.4M |
| Q2 2026 | -$17M | +$2.3M |
| Q1 2026 | -$16.1M | +$8.5M |
| Q4 2025 | -$17.8M | -$8.8M |
| Q3 2025 | -$17.4M | +$3.6M |
| Q2 2025 | -$19.4M | +$1.2M |
| Q1 2025 | -$24.6M | +$2.9M |
| Q4 2024 | -$8.9M | +$38.7M |
KRRO has burned cash in almost every quarter: −$64M over the past year, against −$70M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over KRRO on cash generation, producing positive trailing cash flow while its opponent burns cash.
KRRO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.4% | +249K shares |
| 1 year | +90% | +8.5M shares |
| 3 years | +2399% | +17.2M shares |
| 5 years | +2519% | +17.2M shares |
| Available history | +2794% | +17.2M shares |
KRRO has 18M diluted shares, up 90% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over KRRO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
KRRO Net Leverage
KRRO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
KRRO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.3 | Neutral |
| Stochastic | 75.0 | Neutral |
KRRO's weekly RSI is 55 (neutral) and its Stochastic is 75 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
KRRO PE vs Healthcare Sector
KRRO has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
KRRO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.7 | 23% above |
| 20 week MA | $12.2 | 17% above |
| 50 week MA | $11.6 | 23% above |
| 100 week MA | $18.0 | 20% below |
| 200 week MA | $32.3 | 56% below |
KRRO has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 56% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over KRRO on trend strength, trading above more of its moving averages.
KRRO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $917.0 | $1,686.0 | +84% |
| 2021 | $1,686.0 | $272.0 | -84% |
| 2022 | $272.0 | $129.5 | -52% |
| 2023 | $129.5 | $47.9 | -63% |
| 2024 | $47.9 | $40.0 | -17% |
| 2025 | $40.0 | $8.12 | -80% |
| 2026 YTD | $8.12 | $14.3 | +76% |
KRRO has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.